Search

Displaying results 9651 - 9660 of 10000 in total
  1. Drug

    JZP-386 free base

    go.drugbank.com/drugs/DB17068
    Experimental

    JZP-386 is a deuterium-containing analog of sodium oxybate. Its safety, pharmacokinetics and pharmacodynamics were evaluated in clinical trial NCT02215499.

  2. Drug

    AGuIX

    go.drugbank.com/drugs/DB18189
    Investigational

    It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma. … AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates.

  3. Drug

    Ormeloxifene

    go.drugbank.com/drugs/DB13310
    Experimental

    activity in the uterus and breast. … [A251450,A251460] Ormeloxifene is marketed in India as a racemic mixture of the l- (levormeloxifene) and d-isomers (d-ormeloxifene) of _trans_-ormeloxifene.

  4. Drug

    Enlonstobart

    go.drugbank.com/drugs/DB21890
    Investigational

    [A274486] Enlonstobart is currently under investigation in clinical trial NCT06998771 (JSKN003 Combined Treatment of HER2-positive Gastric Cancer). … [A274486] It targets the programmed cell death protein 1 (PD-1), is being developed by the CSPC Pharmaceutical Group for the treatment of advanced cervical cancer and other solid tumours.

  5. Drug

    Rhamnose

    go.drugbank.com/drugs/DB02961
    Investigational

    A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides. [PubChem]

  6. Drug

    TC-6987

    go.drugbank.com/drugs/DB14854
    Investigational

    TC-6987 is under investigation in clinical trial NCT01296087 (TC-6987 for the Treatment of Mild to Moderate Asthma).

  7. Drug

    Vantictumab

    go.drugbank.com/drugs/DB12956
    Investigational

    Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.

  8. Drug

    Eltanolone

    go.drugbank.com/drugs/DB12308
    Experimental

    Eltanolone is under investigation in clinical trial NCT02603926 (Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone).

  9. Drug

    E59

    go.drugbank.com/drugs/DB18372
    Experimental

    E59 is a humanized IgG1 low affinity allergic reactivity inhibiting (LARI) monoclonal antibody. It was developed by Sixal Inc.

  10. Drug

    Coprelotamab

    go.drugbank.com/drugs/DB16380
    Investigational

    Coprelotamab is under investigation in clinical trial NCT04170595 (Clinical Study of Recombinant Anti-her2 Humanized Monoclonal Antibody for Injection).